Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 446-630-3 | CAS number: 181587-01-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 Mar - 12 Apr 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- Adopted in 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Department of Science and Technology, Government of India
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 446-630-3
- EC Name:
- -
- Cas Number:
- 181587-01-9
- Molecular formula:
- C13H9Cl2F3N4OS
- IUPAC Name:
- 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(ethanesulfinyl)-1H-pyrazole-3-carbonitrile
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Intox PVT. Ltd.
- Females nulliparous and non-pregnant: yes
- Age at start of treatment: 8 weeks
- Body weight at start of treatment: 145 - 155 g (females)
- Fasting period before study: Yes, rats were fasted overnight prior to dosing. Food was offered 3 - 4 h after dosing.
- Housing: group housing, 3 animals of the same dose group in one cage (cage size: 35 cm (L) x 22 cm (W) x 18 cm (H)), in sterilized solid bottom polypropylene cages with stainless steel grill tops and sterilized paddy husk bedding
- Diet: extruded pelleted rat feed Altromin (manufactured by M/s Altromin Spezialfutter GmbH & Co. KG, Germany, and supplied by ATNT Laboratories, Mumbai, India), ad libitum
- Water: filtered water of drinking water quality, ad libitum
- Acclimation period: 7 - 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23
- Humidity (%): 38 - 66
- Air changes (per hr): 11.03 - 14.6
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 19 Mar 2016 To: 12 Apr 2016
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: analytical grade water with 0.2% Tween 80
- Details on oral exposure:
- VEHICLE
- Test substance concentration in vehicle: 200 mg/mL
- Amount of vehicle: 10 mL/kg bw
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
DOSAGE PREPARATION: Formulations of the test substance were prepared freshly before dosing on each day. The test substance was suspended in analytical grade water with 0.2% Tween 80 as a wetting agent.
CLASS METHOD
- Rationale for the selection of the starting dose: A previous acute toxicity study revealed that the oral LD50 value in male and female rats is >7080 mg/kg bw. Based on the available information, the present study was started at the dose level of 2000 mg/kg bw, according to OECD TG 423. - Doses:
- 2000 mg/kg bw (step 1 and step 2)
- No. of animals per sex per dose:
- 3 female animals per group; two groups were tested stepwise in 2 consecutively steps (referred as step 1 and step 2)
- Control animals:
- no
- Remarks:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for mortality twice a day throughout the observation period. Following test substance administration, animals were observed for clinical signs of toxicity 10 min, 30 min, 1 h, 2 h and 4 h post dosing and periodically thereafter for the first 24 h post dosing. During the 14-day observation period, animals were observed at least once a day. Body weight was measured at one day prior to dosing (Day 0), on the day of dosing (Day 1, fasting body weight), on Day 7 and at study termination on Day 15.
- Necropsy of survivors performed: yes - Statistics:
- Body weight gain and group mean values were calculated.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- No mortality occurred during the study period.
- Clinical signs:
- other: No clinical signs of toxicity were observed up to the end of the 14-day observation period.
- Gross pathology:
- Necropsy revealed no substance-related findings.
Any other information on results incl. tables
Table 1. Acute oral toxicity
Dose [mg/kg bw] |
Mortality |
Clinical signs |
|
N* |
N* |
Females |
||
2000 |
0/6 |
0/6 |
*N = number of animals/ number of animals used (shown as combined values from step 1 and step 2)
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- In the present acute oral toxicity study in rats no mortality (0/6 rats) occured after single gavage of 2000 mg/kg bw of the test substance.
CLP: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.